Control of multi-drug-resistant Acinetobacter baumannii outbreaks in an intensive care unit: Feasibility and economic impact of rapid unit closure

Journal of Hospital Infection

Volumn 82, Issue 4, 2012, Pages 290-292

  Ayraud Thevenot S ^a,c   Huart, C ^a   Mimoz, O ^a,b,c   Taouqi, M ^a   Laland, C ^a   Bousseau, A ^a   Castel, O ^a,c  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE POITIERS   (France)

Author keywords

Acinetobacter baumannii; Control measure; Cost; Multi drug resistant; Outbreak

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; BACTERIAL STRAIN; CLINICAL ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; ECONOMIC ASPECT; HUMAN; INTENSIVE CARE UNIT; MULTIDRUG RESISTANCE; NONHUMAN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HEALTH EXPENDITURES; HEALTH FACILITY CLOSURE; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS;

EID: 84869231856     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.08.016     Document Type: Article

References (4)

1. Villegas M.V., Hartstein A.I. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003, 24:284-295.
2. Karageorgopoulos D.E., Falagas M.E. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008, 8:751-762.
3. Lee N.Y., Lee H.C., Ko N.Y., et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007, 28:713-719.
4. Garlantézec R., Bourigault C., Boles J.M., et al. Cost-analysis of an intensive care unit closure due to an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak. J Hosp Infect 2011, 77:169-185.